2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Pain, Postoperative
9
Pain
5
Neuralgia
5
Breast Neoplasms
5
Agnosia
4
Neoplasms
3
Head and Neck Neoplasms
2
Chronic Pain
2
Visceral Pain
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Seizures
1
Pinealoma
1
Persistent Postoperative Pain
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Obesity
1
Neuroectodermal Tumors, Primitive
1
Myotoxicity
1
Mouth Neoplasms
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Follicular
1
Lymphoma
1
Liver Neoplasms
1
Leiomyoma
1
Inflammation
1
Hot Flashes
1
Interventions
resiniferatoxin
3
Ketamine
3
Morphine
2
Methadone
2
Dexmedetomidine
2
ziconotide
1
substance P-saporin
1
Standard of Care
1
Sodium Chloride
1
Ropivacaine
1
Registries
1
Pregabalin
1
Passive Cutaneous Anaphylaxis
1
Midazolam
1
Lidocaine
1
Infusion Pumps, Implantable
1
Hydromorphone
1
Fentanyl
1
Calcium Dobesilate
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain, Intractable
×
Pregabalin
×
Clear all
NCT00381095
2021-01-20
COPE
Pfizer
Phase 4
Terminated
152 enrolled
14 charts